Gastroenterology & Hepatology

• 

  Publication Venue For

  • Potassium-Competitive Acid Blockers: Present and Potential Utility in the Armamentarium for Acid Peptic Disorders..  18:693-700. 2022
  • Diagnosis and Management of Refractory Gastroesophageal Reflux Disease..  17:305-315. 2021
  • Lifestyle interventions beyond diet and exercise for patients with nonalcoholic fatty liver disease.  16:119-130. 2020
  • What can we learn from cancer disparities?.  16:134. 2020
  • Therapeutic Endoscopic Ultrasound..  11:467-473. 2015
  • Endoscopy unit efficiency..  10:315-317. 2014
  • NASH in special populations.  10:262-264. 2014
  • Endoscopic ultrasound: common challenging scenarios..  9:819-821. 2013
  • Extrahepatic manifestations of acute hepatitis B virus infection.  9:123-126. 2013
  • Direct-acting antiviral medications for chronic hepatitis C virus infection..  7:154-162. 2011
  • Telaprevir in the treatment of patients with genotype 1 hepatitis C.  6:303-305. 2010
  • Commentary.  5:14-15. 2009
  • Novel protease and polymerase inhibiting agents to treat chronic hepatitis C infection.  4:5-13. 2008
  • Pulmonary eosinophilia following infliximab treatment for Crohn's disease: Review.  2:597. 2006
  • Review..  2:597. 2006
  • Clinical Utility of Biomarkers of Liver Fibrosis..  2:48-57. 2006